Exercise-induced proteinuria is attenuated by indomethacin

Area of Science:

• Exercise Physiology
• Renal Physiology
• Endocrinology

Background:

• Exercise can transiently increase protein excretion in urine (proteinuria).
• The hormonal systems influencing exercise-induced proteinuria are not fully understood.
• Key systems implicated include prostaglandin (PG) and renin-angiotensin (RA) pathways.

Purpose of the Study:

• To investigate the roles of prostaglandin and renin-angiotensin systems in exercise-induced proteinuria.
• To determine if pharmacological inhibition of these systems affects proteinuria during submaximal exercise.

Main Methods:

• Eight healthy males underwent 30-minute cycle ergometry at 75% VO2peak.
• Treatments included placebo, indomethacin (prostaglandin inhibitor), and captopril (ACE inhibitor).
• Urine and blood samples were collected pre-exercise, post-exercise, and during 40-minute recovery.

Main Results:

• Exercise significantly increased proteinuria during the placebo trial.
• Prostaglandin inhibition (indomethacin) significantly attenuated exercise-induced proteinuria.
• Angiotensin-converting enzyme inhibition (captopril) did not alter the proteinuric response.
• Indomethacin blunted plasma renin activity response to exercise, but aldosterone response remained.
• Hemodynamic factors (MAP, sodium excretion, urine flow, creatinine clearance) were unaffected by treatments.

Conclusions:

• Exercise-induced proteinuria is prostaglandin-dependent.
• The renin-angiotensin system does not appear to play a significant role in this response.
• Hemodynamic changes are unlikely to be the primary drivers of exercise-induced proteinuria.